MIR548BA host gene (MIR548BAHG)

The "MIR548BA host gene" (also known as AC009975.1 or MIR548BAHG) is not a canonical drug target such as a receptor, enzyme, transporter, or established therapeutic target. It refers to the genomic locus or non-coding RNA transcript that hosts the microRNA hsa-miR-548ba. According to current evidence, the host gene itself is a non-coding RNA gene, sometimes also annotated as a long non-coding RNA (lncRNA), and is not known to code for any protein or to have a direct biological function independently of the microRNA it hosts. The primary biological importance appears to be its role in harboring the miR-548ba microRNA, which has functions in regulating gene expression post-transcriptionally, including roles in ovarian follicle development via targets such as LIFR, PTEN, and NEO1[1]. However, the host gene (AC009975.1) itself is not established as an independent therapeutic or pathological target, and current databases and literature do not assign to it a clear, distinct molecular, functional, or disease classification outside of its role in non-coding RNA biology[1][6]. Key context: - "MIR548BA host gene" and "AC009975.1" both refer to a *non-coding* RNA gene that serves as the host for the microRNA hsa-miR-548ba[6]. - The functional relevance in the literature centers on the microRNA (hsa-miR-548ba), not the host gene itself. The microRNA has validated targets such as LIFR and PTEN in granulosa cells, impacting ovarian follicle development[1]. - There is no evidence that the host gene functions as a canonical therapeutic target, nor is it formally classified under drug target families. - "MIR548BA host gene" is a description, not a standardized gene symbol recognized in therapeutic targeting. "MIR548BAHG" is an abbreviation constructed by convention, not an official designation[6]. - Some studies reference AC009975.1 as a long non-coding RNA; its best-established identity is as a genomic locus for the MIR548BA microRNA, not an independent functional gene[6]. - No interacting drugs, mechanisms of action, biomarker roles, or safety concerns are described for the host gene itself in current biomedical literature. Summary of why this is considered incorrect as a drug target: - It is **not a receptor, enzyme, transporter, or relevant protein**; it is a non-coding host gene[6]. - It **lacks evidence for direct involvement in disease** independent of the microRNA it encodes[1][6]. - It **has no direct small molecule or biologic modulators**, nor is it pursued as a target for patient selection or efficacy monitoring. If your intent was to obtain information about the microRNA "hsa-miR-548ba" itself, more information is available about its function, targets (LIFR, PTEN, NEO1), and disease associations (reproductive biology, ovarian function)[1]. The host gene (AC009975.1) is not a recognized therapeutic target.

Other names

AC009975.1